Corporate News Report – Spire Healthcare Group PLC
Market Performance (24‑Hour Period Ending 23 October 2026, 04:05 PM Central Europe)
| Item | Value |
|---|---|
| Trading session | Flat 0 % |
| Current share price | GBX 247.5 |
| Total shares outstanding | 402.8 million |
| Market capitalisation | GBX 1.7 billion |
| Volume traded in last 24 h | GBX 2.9 billion |
| Year‑to‑date change | +0.81 % |
| 200‑day simple moving average | GBX 207.52 |
| 52‑week high | GBX 249.5 (19 October 2026) |
| 52‑week low | GBX 140.8 (30 March 2026) |
Recent Regulatory Disclosures
On 22 October 2026, filings under the UK Takeover Code revealed that key investors in Spire Healthcare Group plc had reached or surpassed the 1 % voting‑rights threshold:
- JPMorgan Chase (including J.P. Morgan Securities PLC) reported holdings of approximately 5 % of the company’s voting rights, combining direct share ownership with cash‑settled derivatives.
- BlackRock, American Century Investment Management, Dimensional Fund Advisors, Syquant Capital, and Barclays disclosed positions ranging from about 1 % to 4 % of shares, primarily expressed through a mix of ordinary shares and derivative instruments.
These disclosures provide a clearer view of the ownership structure and may influence market perceptions of governance and potential future proposals.
Comparative Performance of Related Stocks (Past 24 Hours)
| Stock | % Change | Current Price (GBX) | Market Capitalisation (GBX) | P/E Ratio |
|---|---|---|---|---|
| Shawbrook (SHAW.L) | +1.55 % | 283.5 | 2 billion | 7.93 |
| Kainos (KNOS.L) | +2.80 % | 1,311.28 | 2.1 billion | 37.65 |
| Genus (GNS.L) | +0.90 % | 2,264 | 2 billion | 5.29 |
| Vesuvius (VSVS.L) | –1.16 % | 445 | 2 billion | 29.84 |
| Firstgroup (FGP.L) | +1.54 % | 213.8 | 2 billion | 10.46 |
Additional Regulatory Activity – Vesuvius PLC
On 22 October 2026, several institutional investors filed sizable positions in Vesuvius PLC under the Takeover Code. Firms such as Pentwater Capital Management, the Vanguard Group, and BlackRock reported holdings exceeding the 1 % threshold, expressed through ordinary shares and related derivatives. These filings also indicated concurrent positions in RHI Magnesita N.V., highlighting the interconnected nature of the ongoing offer to Vesuvius. The disclosures, released via regulated news services, offer market participants a clearer picture of the ownership landscape and the active interest of major asset managers in the company’s shares.
About Spire Healthcare Group PLC
Spire Healthcare Group plc is a private healthcare provider operating throughout the United Kingdom. The company offers a range of health‑care services, including primary, acute, and specialist care, through its network of hospitals, clinics, and community health facilities.
